Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 151.21M | 118.83M | 149.75M | 170.57M | 94.51M | 108.16M |
Gross Profit | 34.10M | 27.23M | 32.61M | 34.13M | 16.41M | 19.00M |
EBITDA | -410.00K | -14.02M | -3.85M | 21.13M | -14.01M | -14.12M |
Net Income | -6.23M | -17.60M | -4.96M | 19.21M | -16.69M | -16.99M |
Balance Sheet | ||||||
Total Assets | 66.93M | 59.94M | 68.15M | 73.95M | 64.88M | 52.96M |
Cash, Cash Equivalents and Short-Term Investments | 6.25M | 10.86M | 17.11M | 27.18M | 10.27M | 16.94M |
Total Debt | 23.55M | 25.58M | 21.39M | 13.91M | 26.38M | 7.10M |
Total Liabilities | 48.95M | 43.74M | 34.43M | 35.37M | 45.49M | 16.92M |
Stockholders Equity | 17.98M | 16.20M | 33.72M | 38.58M | 19.38M | 36.04M |
Cash Flow | ||||||
Free Cash Flow | -2.75M | -9.03M | -24.88M | 9.18M | -16.03M | -15.55M |
Operating Cash Flow | -2.25M | 188.00K | -8.92M | 9.18M | -15.93M | -15.18M |
Investing Cash Flow | -413.00K | -9.13M | -8.31M | 22.74M | -9.09M | -349.00K |
Financing Cash Flow | 2.94M | 1.94M | 15.63M | -1.46M | 2.87M | -1.46M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $253.57B | 15.11 | 28.11% | 2.56% | 11.51% | 47.88% | |
78 Outperform | $365.82B | 9.57 | 11.58% | 1.70% | 8.61% | 16.84% | |
74 Outperform | $84.26B | 12.45 | 18.17% | 8.92% | 12.76% | 34.50% | |
56 Neutral | HK$24.59B | 3.77 | -2.05% | 6.59% | -0.32% | -67.68% | |
47 Neutral | HK$32.40M | 54.00 | 3.64% | ― | 37.57% | 67.57% |